|
 |
LeukemiasThis page contains recent news articles, when available, and an overview of Leukemias but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Background information on Leukemias
NewsBusters...unconscionable is leukemias and lymphomas for children who have been affected by this uranium that has been part of our weapon system that was dropped Vorinostat Promising in AML - Mar 19, 2008 Cancerpage.com,The remaining patients had other leukemias or myelodysplastic syndrome. All of the patients had relapsed, had refractory disease or were not candidates for Flow Cytometry and Molecular Genetics for Hematologic Neoplasms - Mar 21, 2008 Medscape (subscription)...[13] There are still many lymphomas and leukemias that show no specific cytogenetic abnormalities. These entities may have abnormal karyotypes reported in Back on the academic track - Mar 17, 2008 Staten Island Advance - SILive.com,Leukemias, the report states were the most common diagnoses and the death rates for these blood cancers declined by 3 percent per year. Pregnant Women Exposed to Pesticides May Up Leukemia Risk in Children - Mar 25, 2008 Fashion Monitor Toronto,In the United States, approximately 27% of all childhood cancers are leukemias. It is estimated that in 2007, 3800 children under the age of 20 will be Elizabeth Blackburn: Because science is worth it - Mar 24, 2008 Journal of Cell Biology (subscription)Janet Rowley, who won the National Medal of Science and who discovered the recurring chromosomal translocations that characterize leukemias and other New Drug Approved for Chronic Lymphocytic Leukemia - Mar 22, 2008 ACS News Center,Chronic lymphocytic leukemia accounts for about one third of all leukemias. According to Cancer Facts and Figures 2008, the American Cancer Society's annual PET/CT May Unmask Hidden Cancers in Li-Fraumeni Patients - Mar 20, 2008 MedPage Today,...individuals to early onset of diverse malignancies that include sarcomas, breast cancer, brain tumors, adrenocortical carcinomas, and leukemias. Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non ... - Mar 20, 2008 Earthtimes,...and the second-generation proteasome inhibitor NPI-0052 is being developed in patients with solid tumors, lymphomas, leukemias and multiple myeloma. Childhood cancer death rates drop - Mar 17, 2008 Staten Island Advance - SILive.com,Leukemias were the most common diagnoses (25.5 percent), and they declined by 3 percent per year. While the death rates are decreasing, the incident rates MorphoSys Obtains Agreement for Production of Antibody Material in ... - Mar 16, 2008 StreetInsider.com (subscription),MOR202 is a fully human HuCAL antibody directed against CD38, a therapeutic target for the treatment of multiple myeloma and certain leukemias. Katrina Victims Still Struggle With Housing Problems - Mar 14, 2008 PBS...very high levels of formaldehyde exposure, there have been correlations with blood disorders, leukemias, nasal cancers, nasopharyngeal cancers. ChemGenex Launches Multi-Site Omacetaxine Clinical Trial in AML ... - Mar 11, 2008 PharmaLive.com (press release),..."Our understanding of the mechanism of action of omacetaxine, along with previous clinical experience in a range of leukemias, particularly in CML patients, Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 ... - Mar 11, 2008 Earthtimes,Sunesis updated the results from the company's Phase 1 clinical trial of single-agent SNS-595 in patients with relapsed or refractory acute leukemias, Passion, Pure Research and Happy Accidents - Mar 7, 2008 University of British Columbia,For instance, Dr. Hugh Brock, Director of the UBC Genetics Graduate Program, discovered a protein that helped address untreatable childhood leukemias while Automatic cancer compensation possible for Hanford workers - Mar 7, 2008 Mid Columbia Tri City Herald,The cancers covered under the special exposure cohorts include bone cancer, renal cancer, some leukemias, some lung cancers, multiple myeloma, Monticello lung cancer deaths 'elevated' - Mar 3, 2008 Deseret News,...of these were diagnosed prior to 1973 — including many of the leukemias — and some were diagnosed outside of Monticello, after residents moved away. ... Go to the Article - Mar 3, 2008 CancerWiseAn experimental vaccine for patients with leukemia produced an immune response in 60% of patients with myeloid leukemias and myelodysplastic syndrome (MDS) Senate's Plan to Ban Aspartame 'Deferred': Health Committee Passes ... - Feb 26, 2008 Hawaii Reporter,This was a carefully done study that clearly demonstrated a statistically significant increase in several types of lymphomas and leukemias in rats. New study: influence of anthracycline upon HER2 breast cancer - 27 Dec 2007 Pravda,...used to treat a wide range of cancers, including (but not limited to) leukemias, lymphomas, and breast, uterine, ovarian, and lung cancers. Sunesis Pharmaceuticals' SNS-595 Shows Clinical Activity in ... - Dec 10, 2007 CNNMoney.comThese data were presented today by Dr. Lancet in the "Acute Myeloid Leukemias: Therapy, excluding Transplantation-Novel Therapies" oral session. In Depth Report Analyzes Three Major and Intertwined Areas of ... - Dec 19, 2007 Business Wire (press release),In this triple analysis report we have analyzed three major and intertwined areas of cancer R&D, Antibody drug target, Leukemias and Lymphomas, Preliminary Results from VioQuest Pharmaceuticals' Phase I Trial ... - Dec 10, 2007 Business Wire (press release),..."To date, we've seen significant reductions in peripheral blood myeloblasts among some patients with advanced leukemias that were refractory to prior Damon Runyon Cancer Research Foundation Awards Prestigious ... - Dec 25, 2007 Medical News Today (press release),Chromosomal translocations of NPC proteins are linked to various types of cancer, including myeloid and lymphoid leukemias. 9. Gianna Elena Hammer, PhD, Leukemia, Lymphoma Awareness raised by students - Dec 3, 2007 Quad (subscription),The difference between acute and chronic leukemias is the presence of blast cells, which are immature blood-forming cells. Acute leukemias have them; S*BIO Expands Pipeline With the Development of a Unique Flt3 -CDK ... - Nov 27, 2007 PR Newswire (press release),This is a novel orally-available small molecule compound targeted for the treatment of acute leukemias. SB1317 is designed to selectively inhibit major Childhood Cancer Death Rate Down - Dec 6, 2007 WebMDFor 2004 -- the most recent year for which CDC childhood cancer statistics are available -- leukemias were the leading cause of childhood cancer death. Cyclacel Pharmaceuticals Announces - Dec 5, 2007 Ad-Hoc-News (Pressemitteilung),Title: Phase I Study of Sapacitabine, an Oral Nucleoside Analogue, in Patients with Advanced Leukemias or Myelodysplastic Syndromes (MDS). Full Text - Dec 13, 2007 Science Magazine (subscription)Thus, many mouse lymphomas and leukemias, including ones closely modeling human counterparts and involving equivalent genetic changes and stochastic onset, Cyclacel Pharmaceuticals "buy" - Dec 10, 2007 newratings.com,...its sapacitabine drug, in the treatment of advanced leukemias or myelodysplastic syndromes (MDS), reflects a marginal improvement in the response rate. Buried coal - Nov 29, 2007 Reno News & Review,St. George was the hardest hit community during the days of Nevada atomic testing, which created a swath of cancers and leukemias east and north of the Pharmion Presents Clinical Data Demonstrating Significant Survival ... - Dec 9, 2007 CNNMoney.comSession: Acute Myeloid Leukemias: Therapy, Excluding Transplantation I -- Poster Board No. 65-I: Report of a Phase I/II Study of 5-Azacitidine and Hana Biosciences Presents Marqibo Data At the 49th Annual Meeting ... - Dec 8, 2007 CNNMoney.com...during the session entitled Acute Lymphocytic Leukemias: Therapy, excluding Transplantation. Data from two clinical trials were integrated for the Pharmion to Present Clinical Data on Key Hematology Products at ... - Dec 6, 2007 PR Newswire (press release),Date / Time / Location: December 10, 2007; 1:30-3:00 pm, Rooms A411-A412, Georgia World Congress Center Session: Acute Myeloid Leukemias: Therapy, Data from INNOVIVE Pharmaceuticals’ Oncology Drug Programs to be ... - Dec 5, 2007 Business Wire (press release),Abstract # 469: “A Phase I Study of INNO-406 in Patients with Advanced Philadelphia (Ph+) Chromosome-Positive Leukemias Who Are Resistant or Intolerant to Modern Hematology: Biology and Clinical Management - Dec 11, 2007 Journal of American Medical Association (subscription),This format is likewise followed for the acute leukemias and multiple myelomas. The acute leukemias and myelodysplasia are covered, with the new emphasis on ChemGenex Investigators Report Omacetaxine Effective in Killing ... - Dec 11, 2007 Business Wire (press release),Mcl-1 is a key target protein in several types of leukemias and other cancers, and is believed to be one of the major targets through which omacetaxine Cyclacel Pharmaceuticals Provides Year End 2007 Pipeline Update ... - Dec 4, 2007 PR-USA.net (press release),Updated data from the ongoing Phase I trial of oral sapacitabine in patients with advanced acute myelogenous leukemias (AML) or myelodysplastic syndromes BioCryst's forodesine HCI shows positive results in Phase I/II trial - Dec 14, 2007 CNNMoney.comForodesine HCI is used to treat certain types of leukemias and lymphomas. '[The] data concluded that in addition to a good safety profile, forodesine HCI Data Presented at 2007 ASH Meeting Demonstrate Activity of ... - Dec 14, 2007 CNNMoney.com...and in vitro data evaluating forodesine HCl, the Company's lead anti-cancer compound, in the treatment of certain types of leukemias and lymphomas. Leukemia treatment has come a long way in recent years - Dec 21, 2007 Philadelphia Daily News,..."One thing that has evolved is that we are able to look more carefully at the type of leukemias or the cancers and define what's good and what's bad," Evans Researcher Develops Test For Targeted Therapy In Acute Myeloid ... - Dec 10, 2007 Science Daily (press release)It may also be possible to identify mechanisms as to why certain leukemias respond well to therapy and why others may not. The real novelty of our work is EntreMed Presents Results for ENMD-1198 and Vincristine in ... - Dec 10, 2007 CNNMoney.comCombination studies with ENMD-1198 and another microtubule targeting agent commonly used in the treatment of leukemias, vincristine, demonstrate synergistic Pharmacyclics Announces Presentation of Results from Phase 1/2 ... - Dec 10, 2007 CNNMoney.com...in cell signaling and have been targets for other drugs such as Gleevec(R) (imatanib mesylate), which is approved for treatment of certain leukemias. Fierce determination pays off - Dec 20, 2007 Waterloo Record,In a way, a small part of his battle was fought for him in that his cancer has one of the highest cure rates of all pediatric leukemias. AstraZeneca PLC - Research Update - Dec 7, 2007 ReutersIn addition, MedImmune will also discuss its anti-CD22 programme in Phase I development for certain leukemias and lymphomas. Also expected in the next 24 Scientists Reveal Role Of Gene In Sensitivity To Thermal Pain - Dec 6, 2007 Science Daily (press release)...a few years ago revolutionized the treatment of breast cancer, leukemias and gastrointestinal stromal tumors, but also can apparently alleviate pain. EpiCept Announces Presentation of New Ceplene(TM) Data at the 49th ... - Dec 3, 2007 CNNMoney.comSession Name: Acute Myeloid Leukemias - Therapy, excluding Transplantation. Presenter: Mats L. Brune, et al; University of Goteborg, Goteborg, Sweden. Sunesis Pharmaceuticals to Present Data on Two Product Candidates ... - Nov 29, 2007 Reuters...a replication-dependent DNA damaging agent, as part of the oralsession "Acute Myeloid Leukemias: Therapy, excluding Transplantation-NovelTherapies. Sunesis Pharmaceuticals to Present Data on Two Product Candidates ... - Nov 29, 2007 CNNMoney.com...a replication-dependent DNA damaging agent, as part of the oral session "Acute Myeloid Leukemias: Therapy, excluding Transplantation-Novel Therapies. MethylGene to Present Clinical Data for MGCD0103 at the 49th ... - Nov 29, 2007 ReutersSession: Acute Myeloid Leukemias: Therapy, Excluding Transplantation - Novel Therapies Oral Presentation: Monday, December 10, 2007 at 2:45pm, Rise in CT Scans Poses Cancer Risk - Nov 28, 2007 U.S. News & World Report,..."The leukemias may come up in the first decade, but the solid cancers take a long time." Some 4 million to 5 million CT scans are done on children, Plant Constituent With Selective Effect On Cancer Cells - Dec 18, 2007 Medical News Today (press release),The scientists rate the data as convincing enough to continue testing the suitability of wogonin as a therapeutic agent for leukemias. AstraZeneca Starts Major R&D Push in Biologics - Dec 16, 2007 FDA news (subscription),...ongoing Phase I clinical trial for a treatment for late-stage non-Hodgkin’s lymphoma and a Phase I trial of a treatment for certain leukemias and lymphomas. Father Muller Hosts National Oncology Update - Dec 16, 2007 Mangalorean.com,Dr. L. Appaji, Professor of Paediatric Oncology, Kidwai Institute of Oncology, Bangalore, spoke about Leukemias: the commonest cancers in children. Cyclacel Reports Updated Phase I Sapacitabine Data at 2007 ASH Meeting - Dec 16, 2007 PR-USA.net (press release),Gemcitabine is indicated for the palliative treatment of breast, lung, ovarian and pancreatic cancer, but it has not been reported to be active in leukemias Understanding Chronic Myelogenous Leukemia - Dec 15, 2007 DentalPlans.com,Doctors report an increase in CML and other leukemias following the nuclear bombings of Japan during World War II, so there may be some correlation between Children’s Oncology Group Research Instrumental - Dec 13, 2007 NewsReleaseWire.com (press release)The leading subgroups of cancer deaths continue to be those from leukemias (25.5%) closely followed by brain and other central nervous system neoplasms Media advisory - Nova Scotia Poised to Become First Province to ... - Dec 12, 2007 Canada NewsWire (press release),Research also suggests a link between exposure to second-hand smoke and childhood leukemias, lymphomas, and brain tumours. Laws banning smoking in cars with Sunesis's anti-cancer drug shows clinical activity in leukemia ... - Dec 12, 2007 Trading Markets (press release),...clinical activity when administered either once- or twice-weekly at biologically active doses to patients with relapsed or refractory acute leukemias. INNOVIVE Pharmaceuticals Presents Phase I Data on INNO-406 for ... - Dec 10, 2007 PR-Inside.com (Pressemitteilung),Advanced Philadelphia (Ph+) Chromosome-Positive Leukemias Who Are Resistant or Intolerant to Imatinib and Second Generation Tyrosine Kinase Inhibitors. Market Report -- In Play (SNSS) - Dec 10, 2007 MSN MoneySunesis Pharma's SNS-595 shows clinical activity in patients with Relapsed or Refractory Acute Leukemias Co presented positive results for SNS-595 in S*BIO's Oral JAK2 Inhibitor SB1518 Demonstrates Therapeutic ... - Dec 10, 2007 Earthtimes,...of hematological malignancies while a poster on S*BIO's novel kinase inhibitor SB1317 showed data for the potential treatment of acute leukemias. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer ... - Dec 10, 2007 Earthtimes,...formulation that incorporates a synergistic ratio of cytarabine and daunorubicin for the treatment of advanced leukemias and myelodysplastic syndromes. Innovative Research Advances Stem Cell and Bone Marrow Transplantation - Dec 10, 2007 PR Newswire (press release),...at the annual meeting focusing on blood clotting and bleeding disorders, leukemias, sickle cell disease and thalassemia, and hematologic malignancies. Research Provides Critical Insight into Improving Therapy for ... - Dec 9, 2007 Earthtimes,...take place at the annual meeting focusing on blood clotting and bleeding disorders, leukemias, sickle cell disease and thalassemia, and transplantation. ARIAD Presents Unique Profile of Novel Multi-Targeted Kinase ... - Dec 8, 2007 Business Wire (press release),The incidence of hematological cancers, such as leukemias, lymphomas and myelomas, is among the fastest growing cancers due to the aging population. Advances in Blood Cancer Therapy to be Highlighted at American ... - Dec 5, 2007 PR Newswire (press release),Abnormalities in transcription factor activity are among the most common causes of myeloid and lymphocytic leukemias and are good targets for new drug OncoVista, Inc. Retains Porter, LeVay & Rose, Inc. as Investor ... - Dec 5, 2007 Trading Markets (press release),...compounds in pre-clinical development directed to IND filing, as well as Phase I/II clinical-stage drugs for treatment of solid tumors and leukemias. Search the web for more resources on Leukemias |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2006 MONGABAY.COM |